|
|
|
|
|
|
|
30.07.26 - 14:09
|
Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply (Business Wire)
|
|
|
Resilience and Lilly expand strategic partnership first established in 2023
Investment will significantly increase U.S. production of Lilly's KwikPen® injectable device for diabetes and obesity medicines to meet growing patient demand
400 new high-skilled jobs to be created in the Cincinnati, Ohio region
Coincides with milestone of Resilience having produced more than 150 million doses of Lilly medicines to U.S. patients
CINCINNATI--(BUSINESS WIRE)--Resilience, a technology-forward contract development and manufacturing organization dedicated to broadening access to complex medicines, today announced it has expanded its strategic partnership with Eli Lilly and Company to increase U.S. production of critical medicines featuring new pharmaceutical manufacturing investments in Ohio.
Building on a partnership first established in 2023, $750 million of investment by Resilience and Lilly has expanded Resilience's advanced manufacturing operations in the Cincinnati region, which will now include Lilly's Kwik...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
